Middle East and Africa Artificial Cornea and Corneal Implant Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Human Cornea and Artificial Cornea), Transplant Type (Penetrating Keratoplasty, Endothelial Keratoplasty, and Others), Disease Indication (Fuchs’ Dystrophy, Keratoconus, Fungal Keratitis, and Others), and End User (Hospitals, Specialty Clinics and ASCs, and Others)
Market Introduction
An artificial cornea implant is a surgery to eliminate all or part of a damaged cornea and replace it with healthy donor tissue. But, currently, there shortage of cornea donors worldwide, and eye and tissue banking is also not carrying in many countries. Meanwhile, there is always the possibility that the human eye will reject the transplantation, which can cause infection or lack of vision. Cornea Implant is usually performed under certain conditions such as keratoconus, degenerative disease, or other. The artificial cornea tissue can be made up of polymer plastic such as silica material. Artificial cornea implant is of two types, i.e., synthetic cornea implant and biosynthetic cornea implant.
Get more information on this report :
Market Overview and Dynamics
The Middle East and Africa artificial cornea and corneal implant market is expected to reach US$ 27.78 million by 2028 from US$ 18.46 million in 2021; it is estimated to grow at a CAGR of 6.0% from 2021 to 2028. The key factors that are driving the growth of market are rising prevalence of eye diseases that causes corneal blindness, significantly rising elderly population are factors propelling the artificial cornea and corneal implant market. However, the expensive ophthalmology surgeries and devices may hamper the growth of the Middle East and Africa artificial cornea and corneal implant market in the forecast period.
Rise in geriatric population in developed countries such as the US, the UK and in developing countries such as UAE and Saudi Arabia is driven by the modernization of healthcare facilities and improvements in healthcare services, which have boosted the life expectancy in these countries. According to the United Nation’s World Population Ageing 2017 report, by 2050, all regions of the world, except Africa, would have ~25% or more of their populations aged 60 and above. The loss of vision is a major health problem among the elderlies. At the age of 65, one-third of people suffer from an eye disease with impaired vision. Age-related macular degeneration, glaucoma, cataracts, and diabetic retinopathy are the most common causes of vision loss among the people from this age group. Age-related macular degeneration results in the loss of central vision. Optic nerve injury and visual field loss can occur as a result of primary open-angle glaucoma. As this ailment can be asymptomatic at first, elderly people should have regular check-ups. Although cataracts are a common source of visual issues in these people, surgeries to remove them is usually successful. Diabetic retinopathy is also common among the older people during the early stages of diabetes or at the time of diagnosis. When a patient is diagnosed with diabetes, a mydriatic examination is recommended, as well as once a year thereafter. Thus, the rise in geriatric population is fuelling the artificial cornea and corneal implant market growth.
The healthcare sector in the UAE has undergone a considerable number of infrastructure and procedural changes to position itself as a leading healthcare provider across Middle East. These improvements have been recognized throughout the COVID-19 pandemic due to the continuous investments made to improve the sector’s hard and soft infrastructure. However, the pandemic had a significant impact on healthcare operations in other countries. Due to the COVID-19 pandemic, a substantial number of planned elective surgery operations was cancelled or postponed. The pandemic has brought unprecedented challenges for eye care in the Middle east and Africa. Owing to the increase in the number of COVID-19 confirmed cases in Lagos, hospital managers decided to reduce services to protect staff. Non-urgent follow up appointments, elective surgeries, and clinic consultations were postponed. Only emergency cases of conditions such as retinoblastoma, retinopathy of prematurity, red eye, trauma, and sudden vision los were attended. Similarly, in Ethiopia, eye health units suspended eye examinations and attended only injury-related eye emergencies due to the fear of the spread of novel coronavirus. Elective ocular surgery has been suspended across the country. People with eye diseases, such as bilateral blindness from cataract, are being turned away, even if surgery would improve vision. Also, corrective eyelid surgical services to treat trichiasis have been suspended, leaving hundreds of thousands of people at risk of getting an irreversible vision impairment. Community-based eye health surveys and ongoing research have also been discontinued, which has led to considerable delays in the planning of eye health services.
Key Market Segments
The Middle East and Africa artificial cornea and corneal implant market, based on type, is bifurcated into human cornea and artificial cornea. In 2021, the human cornea segment held a larger share of the market. However, the artificial cornea segment is expected to register a higher CAGR during the forecast period.
The Middle East and Africa artificial cornea and corneal implant market, by transplant type, is segmented into penetrating keratoplasty, endothelial keratoplasty, and others. In 2021, the penetrating keratoplasty segment held the largest share of the market. However, the market for the endothelial keratoplasty segment is expected to grow at the highest rate in the coming years.
The Middle East and Africa artificial cornea and corneal implant market, by disease indication, is segmented into Fuchs’ Dystrophy, keratoconus, fungal keratitis, and others. The Fuchs’ Dystrophy segment held the largest share of the market in 2021, whereas the fungal keratitis segment is anticipated to register the highest CAGR of the market during the forecast period.
The Middle East and Africa artificial cornea and corneal implant market, based on end user, is segmented into hospitals, specialty clinics and ASCs, and others. The specialty clinics and ASCs segment held the largest share of the market in 2021 and is anticipated to register the highest CAGR of the market during the forecast period.
Major Sources and Companies Listed
A few of the primary and secondary sources referred to while preparing the report on the Middle East and Africa artificial cornea and corneal implant market are the International Diabetes Federation (IDF), World Health Organization (WHO), and Ethiopian Ministry of Health (EMoH).
Reasons to buy the report
- Determine prospective investment areas based on a detailed trend analysis of Middle East and Africa artificial cornea and corneal implant market over the next years.
- Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
- Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
- Identify the major channels driving the Middle East and Africa artificial cornea and corneal implant market, providing a clear picture of future opportunities that will help analyze, resulting in revenue expansion.
- Channelize resources by focusing on the ongoing programs undertaken by the different countries within the Middle East and Africa artificial cornea and corneal implant market.
MIDDLE EAST AND AFRICA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET SEGMENTATION
By Type
- Human Cornea
- Artificial Cornea
By Transplant Type
- Penetrating Keratoplasty
- Endothelial Keratoplasty
- Others
By Disease Indication
- Fuchs’ Dystrophy
- Keratoconus
- Fungal Keratitis
- Others
By End User
- Hospitals
- Specialty Clinics and ASCs
- Others
By Country
- UAE
- South Africa
- Saudi Arabia
- Rest of Middle East and Africa
Company Profiles
- AJL OPHTHALMIC S.A
- EyeYon Medical
- KERAMED, INC.
- Florida Lions Eye Bank
- Corneat Vision
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Middle East and Africa Artificial Cornea and Corneal Implant Market – By Type
1.3.2 Middle East and Africa Artificial Cornea and Corneal Implant Market – By Transplant Type
1.3.3 Middle East and Africa Artificial Cornea and Corneal Implant Market – By Disease Indication
1.3.4 Middle East and Africa Artificial Cornea and Corneal Implant Market – By End User
1.3.5 Middle East and Africa Artificial Cornea and Corneal Implant Market – By Country
2. Artificial Cornea and Corneal Implant Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Artificial Cornea and Corneal Implant Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Middle East and Africa – PEST Analysis
5. Artificial Cornea and Corneal Implant Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Eye Diseases Causing Corneal Blindness
5.1.2 Significant Rise in Elderly Population
5.2 Market Restraints
5.2.1 High Cost of Ophthalmology Surgeries and Devices
5.3 Market Opportunities
5.3.1 Shortage of Corneal Donors
5.4 Future Trends
5.4.1 3D-Printed Human Corneas
5.5 Impact Analysis
6. Artificial Cornea and Corneal Implant Market – Middle East and Africa Analysis
6.1 Middle East and Africa Artificial Cornea and Corneal Implant Market Revenue Forecast and Analysis
7. Artificial Cornea and Corneal Implant Market Analysis – By Type
7.1 Overview
7.2 Artificial Cornea and Corneal Implant Market, by Type 2021 & 2028 (%)
7.3 Human Cornea
7.3.1 Overview
7.3.2 Human Cornea: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Artificial Cornea
7.4.1 Overview
7.4.2 Artificial Cornea: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (US$ Million)
8. Artificial Cornea and Corneal Implant Market Analysis – By Transplant Type
8.1 Overview
8.2 Artificial Cornea and Corneal Implant Market, by Transplant Type 2021 & 2028 (%)
8.3 Penetrating Keratoplasty
8.3.1 Overview
8.3.2 Penetrating Keratoplasty: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Endothelial Keratoplasty
8.4.1 Overview
8.4.2 Endothelial Keratoplasty: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (US$ Million)
9. Artificial Cornea and Corneal Implant Market Analysis – By Disease Indication
9.1 Overview
9.2 Artificial Cornea and Corneal Implant Market Revenue Share, by Disease Indication (2021 and 2028)
9.3 Fuchs’ Dystrophy
9.3.1 Overview
9.3.2 Fuchs’ Dystrophy: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Keratoconus
9.4.1 Overview
9.4.2 Keratoconus: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Fungal Keratitis
9.5.1 Overview
9.5.2 Fungal Keratitis: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (US$ Million)
10. Artificial Cornea and Corneal Implant Market Analysis – By End User
10.1 Overview
10.2 Artificial Cornea and Corneal Implant Market Revenue Share, by End User (2021 and 2028)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (US$ Million)
10.4 Specialty Clinics and ASCs
10.4.1 Overview
10.4.2 Specialty Clinics and ASCs: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (US$ Million)
10.5 Others
10.5.1 Overview
10.5.2 Others: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (US$ Million)
11. Artificial Cornea and Corneal Implant Market – Middle East and Africa Analysis
11.1 Middle East and Africa: Artificial Cornea and Corneal Implant Market
11.1.1 Overview
11.1.2 Middle East & Africa: Artificial Cornea and Corneal Implant Market- Revenue and Forecast to 2028 (US$ Million)
11.1.3 Middle East and Africa Artificial Cornea and Corneal Implant Market, By Type– Revenue and Forecast to 2028 (USD Million)
11.1.4 Middle East and Africa: Artificial Cornea and Corneal Implant Market, by Transplant Type, 2019–2028 (USD Million)
11.1.5 Middle East and Africa Artificial Cornea and Corneal Implant Market, By Disease Indication – Revenue and Forecast to 2028 (USD Million)
11.1.6 Middle East and Africa Artificial Cornea and Corneal Implant Market, By End User – Revenue and Forecast to 2028 (USD Million)
11.1.7 Middle East and Africa: Artificial Cornea and Corneal Implant Market, by Country, 2021 & 2028 (%)
11.1.7.1 Saudi Arabia: Artificial Cornea and Corneal Implant Market– Revenue and Forecast to 2028 (US$ Million)
11.1.7.1.1 Saudi Arabia: Artificial Cornea and Corneal Implant Market– Revenue and Forecast to 2028 (US$ Million)
11.1.7.1.2 Saudi Arabia Artificial Cornea and Corneal Implant Market, By Type– Revenue and Forecast to 2028 (USD Million)
11.1.7.1.3 Saudi Arabia: Artificial Cornea and Corneal Implant Market, by Transplant Type, 2019–2028 (USD Million)
11.1.7.1.4 Saudi Arabia Artificial Cornea and Corneal Implant Market, By Disease Indication – Revenue and Forecast to 2028 (USD Million)
11.1.7.1.5 Saudi Arabia Artificial Cornea and Corneal Implant Market, By End User – Revenue and Forecast to 2028 (USD Million)
11.1.7.2 UAE: Artificial Cornea and Corneal Implant Market– Revenue and Forecast to 2028 (US$ Million)
11.1.7.2.1 UAE: Artificial Cornea and Corneal Implant Market– Revenue and Forecast to 2028 (US$ Million)
11.1.7.2.2 UAE Artificial Cornea and Corneal Implant Market, By Product Type– Revenue and Forecast to 2028 (USD Million)
11.1.7.2.3 UAE: Artificial Cornea and Corneal Implant Market, by Transplant Type, 2019–2028 (USD Million)
11.1.7.2.4 UAE Artificial Cornea and Corneal Implant Market, By Disease Indication – Revenue and Forecast to 2028 (USD Million)
11.1.7.2.5 UAE Artificial Cornea and Corneal Implant Market, By End User – Revenue and Forecast to 2028 (USD Million)
11.1.7.3 Africa: Artificial Cornea and Corneal Implant Market– Revenue and Forecast to 2028 (US$ Million)
11.1.7.3.1 Africa: Artificial Cornea and Corneal Implant Market– Revenue and Forecast to 2028 (US$ Million)
11.1.7.3.2 Africa Artificial Cornea and Corneal Implant Market, By Type– Revenue and Forecast to 2028 (USD Million)
11.1.7.3.3 Africa: Artificial Cornea and Corneal Implant Market, by Transplant Type, 2019–2028 (USD Million)
11.1.7.3.4 Africa Artificial Cornea and Corneal Implant Market, By Disease Indication – Revenue and Forecast to 2028 (USD Million)
11.1.7.3.5 Africa Artificial Cornea and Corneal Implant Market, By End User – Revenue and Forecast to 2028 (USD Million)
11.1.7.4 Rest of Middle East and Africa: Artificial Cornea and Corneal Implant Market– Revenue and Forecast to 2028 (US$ Million)
11.1.7.4.1 Rest of Middle East and Africa: Artificial Cornea and Corneal Implant Market– Revenue and Forecast to 2028 (US$ Million)
11.1.7.4.2 Rest of Middle East and Africa Artificial Cornea and Corneal Implant Market, By Type– Revenue and Forecast to 2028 (USD Million)
11.1.7.4.3 Rest of Middle East and Africa: Artificial Cornea and Corneal Implant Market, by Transplant Type, 2019–2028 (USD Million)
11.1.7.4.4 Rest of Middle East and Africa Artificial Cornea and Corneal Implant Market, By Disease Indication – Revenue and Forecast to 2028 (USD Million)
11.1.7.4.5 Rest of Middle East and Africa Artificial Cornea and Corneal Implant Market, By End User – Revenue and Forecast to 2028 (USD Million)
12. Impact Of COVID-19 Pandemic on Middle East and Africa Artificial Cornea and Corneal Implant Market
12.1 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
13. Artificial Cornea and Corneal Implant Market–Industry Landscape
13.1 Overview
13.2 Inorganic Growth Strategies
13.2.1 Overview
13.3 Organic Growth Strategies
13.3.1 Overview
14. Company Profiles
14.1 AJL OPHTHALMIC S.A
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 KERAMED, INC.
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 EyeYon Medical
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Florida Lions Eye Bank
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Corneat Vision
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. Middle East and Africa Artificial Cornea and Corneal Implant Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 2. Middle East and Africa Artificial Cornea and Corneal Implant Market, by Transplant Type – Revenue and Forecast to 2028 (USD Million)
Table 3. Middle East and Africa Artificial Cornea and Corneal Implant Market, By Disease Indication – Revenue and Forecast to 2028 (USD Million)
Table 4. Middle East and Africa Artificial Cornea and Corneal Implant Market, By End User – Revenue and Forecast to 2028 (USD Million)
Table 5. Saudi Arabia Artificial Cornea and Corneal Implant Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 6. Saudi Arabia Artificial Cornea and Corneal Implant Market, by Transplant Type – Revenue and Forecast to 2028 (USD Million)
Table 7. Saudi Arabia Artificial Cornea and Corneal Implant Market, By Disease Indication – Revenue and Forecast to 2028 (USD Million)
Table 8. Saudi Arabia Artificial Cornea and Corneal Implant Market, By End User – Revenue and Forecast to 2028 (USD Million)
Table 9. UAE Artificial Cornea and Corneal Implant Market, By Product Type – Revenue and Forecast to 2028 (USD Million)
Table 10. UAE Artificial Cornea and Corneal Implant Market, by Transplant Type – Revenue and Forecast to 2028 (USD Million)
Table 11. UAE Artificial Cornea and Corneal Implant Market, By Disease Indication – Revenue and Forecast to 2028 (USD Million)
Table 12. UAE Artificial Cornea and Corneal Implant Market, By End User – Revenue and Forecast to 2028 (USD Million)
Table 13. Africa Artificial Cornea and Corneal Implant Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 14. Africa Artificial Cornea and Corneal Implant Market, by Transplant Type – Revenue and Forecast to 2028 (USD Million)
Table 15. Africa Artificial Cornea and Corneal Implant Market, By Disease Indication – Revenue and Forecast to 2028 (USD Million)
Table 16. Africa Artificial Cornea and Corneal Implant Market, By End User – Revenue and Forecast to 2028 (USD Million)
Table 17. Rest of Middle East and Africa Artificial Cornea and Corneal Implant Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 18. Rest of Middle East and Africa Artificial Cornea and Corneal Implant Market, by Transplant Type – Revenue and Forecast to 2028 (USD Million)
Table 19. Rest of Middle East and Africa Artificial Cornea and Corneal Implant Market, By Disease Indication – Revenue and Forecast to 2028 (USD Million)
Table 20. Rest of Middle East and Africa Artificial Cornea and Corneal Implant Market, By End User – Revenue and Forecast to 2028 (USD Million)
Table 21. Recent Inorganic Growth Strategies in the Artificial Cornea and Corneal Implant Market
Table 22. Recent Organic Growth Strategies in the Artificial Cornea and Corneal Implant Market
Table 23. Glossary of Terms, Artificial Cornea and Corneal Implant Market
LIST OF FIGURES
Figure 1. Artificial Cornea and Corneal Implant Market Segmentation
Figure 2. Artificial Cornea and Corneal Implant Market Segmentation, By Country
Figure 3. Middle East and Africa Artificial Cornea and Corneal Implant Market Overview
Figure 4. Human Cornea Segment Held the Largest Share of the Type Segment in Artificial Cornea and Corneal Implant Market
Figure 5. Artificial Cornea and Corneal Implant Market – Leading Country Markets (US$ Million)
Figure 6. Middle East and Africa PEST Analysis
Figure 7. Middle East and Africa Artificial Cornea and Corneal Implant Market – Revenue Forecast and Analysis – 2020- 2028
Figure 8. Artificial Cornea and Corneal Implant Market, by Type 2021 & 2028 (%)
Figure 9. Human Cornea: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (US$ Million)
Figure 10. Artificial Cornea: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Artificial Cornea and Corneal Implant Market, by Transplant Type 2021 & 2028 (%)
Figure 12. Penetrating Keratoplasty: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Endothelial Keratoplasty: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Others: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Artificial Cornea and Corneal Implant Market Revenue Share, by (2021 and 2028)
Figure 16. Fuchs’ Dystrophy: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Keratoconus: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Fungal Keratitis: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Others: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Artificial Cornea and Corneal Implant Market Revenue Share, by End User (2021 and 2028)
Figure 21. Hospitals & Clinics: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Specialty Clinics and ASCs: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Others: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Middle East and Africa: Artificial Cornea and Corneal Implant Market, by Key Country – Revenue (2021) (USD Million)
Figure 25. Middle East & Africa Artificial Cornea and Corneal Implant Market Revenue and Forecast to 2028 (US$ Million)
Figure 26. Middle East and Africa: Artificial Cornea and Corneal Implant Market, by Country, 2021 & 2028 (%)
Figure 27. Saudi Arabia: Artificial Cornea and Corneal Implant Market– Revenue and Forecast to 2028 (US$ Million)
Figure 28. UAE: Artificial Cornea and Corneal Implant Market– Revenue and Forecast to 2028 (US$ Million)
Figure 29. Africa: Artificial Cornea and Corneal Implant Market– Revenue and Forecast to 2028 (US$ Million)
Figure 30. Rest of Middle East and Africa: Artificial Cornea and Corneal Implant Market– Revenue and Forecast to 2028 (US$ Million)
Figure 31. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
- AJL OPHTHALMIC S.A
- EyeYon Medical
- KERAMED, INC.
- Florida Lions Eye Bank
- Corneat Vision
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East and Africa artificial cornea and corneal implant market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East and Africa artificial cornea and corneal implant market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.